80 results
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
showed antiviral activity ... virus causing COVID ... ivermectin… #COVID19 ... Virus #Antiviral #Management
Diagnosis and Treatment of Common Causes of Pulseless Electrical Activity (PEA)

#Pulseless #Electrical #Activity #PEA #Differential #Diagnosis
Pulseless Electrical Activity ... Pulseless #Electrical #Activity ... #PEA #Differential ... #Diagnosis #Management
Pulmonary Hypertension Algorithm - Matthew Watto, MD
#Diagnosis #Management #Pulmonary #Hypertension #PAH #Workup #Evaluation #Algorithm #Differential #Curbsiders
Pulmonary Hypertension ... MD #Diagnosis #Management ... #Pulmonary #Hypertension ... Evaluation #Algorithm #Differential
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
for First Time Pulmonary ... Unprovoked • Active ... #PE #Pulmonary # ... Treatment #Algorithm #management
Noncardiogenic Pulmonary Edema - Differential Diagnosis Framework

NCPE Pathophysiology:
Noncardiogenic pulmonary edema occurs because of excessive pulmonary capillary
Noncardiogenic Pulmonary ... Edema - Differential ... renin-angiotensin-aldosterone system activity ... hemorrhage, seizure activity ... #edema #NCPE #differential
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... Recent infection • Pulmonary ... • HIV: 2/3 pulmonary ... Langerhans giant cells ... TB #Diagnosis #Management
Pulmonary Embolism on POCUS Echocardiogram

Mid 30's female with chest pain/dyspnea.  Triage EKG (no prior).
Pulmonary Embolism ... Differential/diagnosis ... Activate cath lab ... thread for POCUS Pulmonary ... RJonesSonoEM #Pulmonary
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Massive Hemoptysis - Differential ... over 24 hours Differential ... Primary Vascular: Pulmonary ... Massive #Hemoptysis #Differential ... #pulmonary #criticalcare
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... -6 activates T cells ... correlate with severe COVID ... Tocilizumab #Siltuximab #COVID19 ... #Pharmacology #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... Recent infection • Pulmonary ... • HIV: 2/3 pulmonary ... Langerhans giant cells ... TB #Diagnosis #Management